한국어
English
日本語
中文(简体)
Lenvima Capsule 10 mg (Lenvatinib Mesylate)
12.25mg
Hard capsule · Prescription medication
Eisai Co., Ltd.
Lenvatinib mesylate is an anticancer agent used to inhibit tumor growth for the treatment of malignant tumors.
MFDS ingredient code M262889
Lenvatinib mesylate belongs to the class of targeted therapy anticancer agents and is primarily used for the treatment of certain malignant tumors such as thyroid cancer and renal cell carcinoma. This ingredient is included in medications for the purpose of inhibiting the growth of tumor cells and angiogenesis.
Lenvatinib mesylate reduces nutrient supply to tumors by blocking signaling pathways that promote blood vessel formation around tumor cells. Additionally, it inhibits growth signals of tumor cells, slowing down or halting the proliferation of cancer cells.
Approved uses differ by product. Check each product's information for its actual use.
Lenvatinib mesylate is a multitargeted inhibitor that acts simultaneously on several receptor tyrosine kinases. As a result, it shows a broader anticancer growth inhibition effect compared to single-target therapies and is utilized for personalized treatment tailored to specific cancer types.
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
Product approval information is based on drug information provided by the Ministry of Food and Drug Safety.
Ingredient and class descriptions are not part of MFDS data and were written separately by Cashdoc.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.
